LifeMD, Inc. (NASDAQ:LFMDP – Get Free Report) was the target of a significant drop in short interest in the month of February. As of February 15th, there was short interest totalling 200 shares, a drop of 33.3% from the January 31st total of 300 shares. Based on an average trading volume of 2,000 shares, the days-to-cover ratio is currently 0.1 days.
LifeMD Price Performance
NASDAQ:LFMDP traded up $0.55 during midday trading on Monday, hitting $23.35. 517 shares of the stock were exchanged, compared to its average volume of 2,441. LifeMD has a one year low of $19.90 and a one year high of $25.00. The business has a 50-day moving average price of $22.38 and a two-hundred day moving average price of $22.32.
LifeMD Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Friday, January 3rd were issued a $0.5547 dividend. The ex-dividend date of this dividend was Friday, January 3rd. This represents a $2.22 annualized dividend and a dividend yield of 9.50%.
LifeMD Company Profile
LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.
Featured Articles
- Five stocks we like better than LifeMD
- What Are Treasury Bonds?
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for LifeMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeMD and related companies with MarketBeat.com's FREE daily email newsletter.
